One reason is that many podcasters looking for a high-end microphone at a lower budget opt for the Shure SM7B, like me! This is a great microphone, but has a very low base output (more on this later). Another reason is that these preamp devices allow you to not go pedal-to-the-metal with your mixer or digital recorders' onboard preamps, which typically add a lot of noise the more you push to maximum.
I am no audio engineering expert, but in my zeal to launch the best podcast that I possibly can, I have learned a lot about how you create good sound and all the tricks that go into doing it at a somewhat modest price.
At heart, what the Fethead and Cloudlifter each do is add about 20-25 decibels of "clean gain" to your microphone's audio signal, before that signal even touches your mixer or digital recorder. Again, they each add only pure, c…
This according to a new feature on Anthony Cumia - formerly of the Opie & Anthony Show - in Streaming Media Magazine and on StreamingMedia.com. Cumia has a video and audio podcast available to subscribers through his Website, AnthonyCumia.com.
The monthly subscription for the content service is $6.95. By my own math, this means Cumia is bringing in about $278,000 per month, or roughly $3.3 million per year.
As a subscriber, you are offered discounts for locking in your subscription for six months ($32.95) or a year ($59.95).
The revenue he is bringing in now must also go towards paying staff, ongoing infrastructure and hosting costs, and any promotional aspects he engages in. Still, he does not leave his home and appears to be d…
Jane Gagliardo, Sherry Blackman, and Patrick Reilly join Melany and Matt for a longform discussion on their riveting book, "Call to Witness: One woman’s battle with disability, discrimination and a pharmaceutical powerhouse."
Jane Gagliardo was a throwaway employee, fired after working nearly a decade for this leading vaccine maker when her disability surfaced. Fearless and impassioned, her story will leave readers empowered to stand up for themselves, even if it means standing alone. This 2002 landmark case changed the law and challenges the way corporations do business today. This riveting dramatic account sheds fascinating insight into the world of vaccine production, both past and present, that will have every reader searching through their immunization record—this corporation literally runs in the veins of millions of Americans.
A portion of the proceeds from the book go to Multiple Sclerosis research.